Clayton Financial Group’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
AACR
HGIM
FI
DC
CF
Clayton Financial Group's ELV Position: Q2 2026 in Review
Clayton Financial Group sold out of Elevance Health (ELV) in Q2 2026, closing a stake of 13 shares — an estimated $3.81K sold.
Clayton Financial Group first reported a position in ELV in Q4 2025 and held it in 2 quarters. The position peaked at $4.56K in Q4 2025. 594 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Clayton Financial Group reported no remaining Elevance Health position as of Q2 2026 after selling out during the quarter.
- Clayton Financial Group sold 13 Elevance Health shares in Q2 2026, an estimated $3.81K.
- Clayton Financial Group first reported a position in Elevance Health in Q4 2025 and held it in 2 quarters.
- Clayton Financial Group's Elevance Health position peaked at $4.56K in Q4 2025.
- 594 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Clayton Financial Group's 13F filing for Q2 2026, filed 20 Jul 2026.